Bu-Shen-Fang-Chuan

compound Chinese medicine consisting of Aconiti Lateralis Radix Praeparata, Semen Cuscutae, Epimedii Folium, Psoraleae Fructus, Dioscoreae Rhizoma, Rehmanniae Radix (drying), Rehmanniae Radix (Steaming and drying), and Citri Reticulatae Pericarpium

Networked: 3 relevant articles (1 outcomes, 1 trials/studies)

Relationship Network

Bio-Agent Context: Research Results

Experts

1.	Cao, Yuxue: 3 articles (10/2020 - 01/2017)
2.	Dong, Jingcheng: 3 articles (10/2020 - 01/2017)
3.	Liu, Baojun: 3 articles (10/2020 - 01/2017)
4.	Wu, Jinfeng: 3 articles (10/2020 - 01/2017)
5.	Li, Lulu: 2 articles (10/2020 - 03/2020)
6.	Li, Qiuping: 2 articles (10/2020 - 03/2020)
7.	Mohammadtursun, Nabijan: 2 articles (10/2020 - 03/2020)
8.	Sun, Jing: 2 articles (10/2020 - 03/2020)
9.	Wang, Guifang: 1 article (10/2020)
10.	Xiong, Shi Hang: 1 article (10/2020)

Related Diseases

1.	Asthma (Bronchial Asthma) 01/01/2017 - "Early studies suggested that Invigorating Kidney and Supplementing Qi herbal formulae, Bu Shen Fang Chuan (BSFC) and Bu Shen Yi Qi (BSYQ), conveyed promising results in asthma treatment. "
2.	Chronic Obstructive Pulmonary Disease (COPD) 10/28/2020 - "Bu-Shen-Fang-Chuan formula (BSFCF) is commonly used for the treatment of COPD in China. " 03/01/2020 - "Our multicenter clinical trial found that Bu-Shen-Fang-Chuan fomula (BSFCF), a Chinese herbal formula, markedly reduced the frequencies of acute exacerbation of COPD and delayed lung function decline. " 03/01/2020 - "Bu-Shen-Fang-Chuan formula attenuates T-lymphocytes recruitment in the lung of rats with COPD through suppressing CXCL9/CXCL10/CXCL11-CXCR3 axis."
3.	Inflammation (Inflammations) 10/28/2020 - "Bu-Shen-Fang-Chuan formula attenuates cigarette smoke-induced inflammation by modulating the PI3K/Akt-Nrf2 and NF-κB signalling pathways."

Related Drugs and Biologics

1.	Smoke